New Delhi: In a trademark dispute between Mankind Pharma Limited and Nectar Biopharma, the Delhi High Court has clarified that Nectar Biopharma cannot use a trade dress deceptively similar to Mankind's popular contraceptive pill "UNWANTED-72", but is free to continue using its own mark "MISTAKE-72."

The ruling was delivered by Justice Manmeet Pritam Singh Arora, who modified an earlier ex-parte ad-interim injunction issued on July 24, 2025, to ensure that the restraint applied only to the impugned trade dress and not to the product name itself.

Mankind Pharma had approached the Delhi High Court alleging that Nectar Biopharma was marketing its product in packaging (trade dress) that closely resembled Mankind’s emergency contraceptive pill “UNWANTED-72.” Mankind argued that such similarit

See Full Page